Dominika Dvorska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dominika Dvorska has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Peter Durdik
Department of Pediatrics and Adolescent Medicine, University Hospital Martin, Kollárová 2, 036 59 Martin, Slovakia
2 shared publications - Alžbeta Soršáková
Department of Pediatrics and Adolescent Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin, 036 59 Martin, Slovakia
1 shared publication - Anna Durdikova
Department of Pediatrics and Adolescent Medicine, University Hospital Martin, Martin, Slovakia
1 shared publication - Anna Sujanska
Department of Pediatrics and Adolescent Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin, 036 59 Martin, Slovakia
1 shared publication - Filip Oleksak
University Hospital Martin
1 shared publication - Jakub Sulov
Department of Pediatrics and Adolescent Medicine, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital Martin, 036 59 Martin, Slovakia
1 shared publication
Latest Publications
- Open Access
Polysomnographic Profile and Clinical Phenotypes of Osa in Association with Residual Sleep Apnea in Children
Introduction: Residual obstructive sleep apnea (OSA) is defined as persistence of the AHI at ≥1 respiratory event per hour of sleep after otorhinolaryngology intervention in pediatric population. In terms of OSA phenotypes in children, we recognize the common, adult, and congenital phenotypes. Material and Methods: We studied 34 pediatric patients with OSA diagnosed by standard overnight polysomnography (PSG). Based on the results, all 34 patients were indicated for adenotonsillectomy (ATE). After 3 months, patients were invited to the sleep laboratory for second control PSG. These OSA patients were divided according to clinical phenotype into two groups: common phenotype and adult phenotype. Results: Residual OSA was diagnosed in 24 patients with a mean AHI 6.67 ± 9.17 after ATE procedure. Incidence of severe residual OSA was 17.6%; moderate residual OSA was 20.6%; mild residual OSA was 32.4%. Residual OSA in classic phenotype was present in eight patients (57.1%). In total, 16 patients with the adult phenotype of OSA (80.0%) were diagnosed with residual OSA. Prevalence was significantly higher in children with the adult phenotype (p < 0.001). Conclusions: We concluded that there is a higher risk of residual OSA in children with the adult phenotype. Phenotyping of children with OSA appears to be an important tool for further management and also in predicting the severity of residual OSA.
Open AccessPolysomnographic Profile and Clinical Phenotypes of Osa in Association with Residual Sleep Apnea in Children
Introduction: Residual obstructive sleep apnea (OSA) is defined as persistence of the AHI at ≥1 respiratory event per hour of sleep after otorhinolaryngology intervention in pediatric population. In terms of OSA phenotypes in children, we recognize the common, adult, and congenital phenotypes. Material and Methods: We studied 34 pediatric patients with OSA diagnosed by standard overnight polysomnography (PSG). Based on the results, all 34 patients were indicated for adenotonsillectomy (ATE). After 3 months, patients were invited to the sleep laboratory for second control PSG. These OSA patients were divided according to clinical phenotype into two groups: common phenotype and adult phenotype. Results: Residual OSA was diagnosed in 24 patients with a mean AHI 6.67 ± 9.17 after ATE procedure. Incidence of severe residual OSA was 17.6%; moderate residual OSA was 20.6%; mild residual OSA was 32.4%. Residual OSA in classic phenotype was present in eight patients (57.1%). In total, 16 patients with the adult phenotype of OSA (80.0%) were diagnosed with residual OSA. Prevalence was significantly higher in children with the adult phenotype (p < 0.001). Conclusions: We concluded that there is a higher risk of residual OSA in children with the adult phenotype. Phenotyping of children with OSA appears to be an important tool for further management and also in predicting the severity of residual OSA.
- Open Access
- 12 September 2024
- Published by Springer Nature in Sleep and Breathing
- Vol. 28 (6) , 2653-2661
Elastography as a non-invasive method of screening non-alcoholic fatty liver disease in the adult phenotype of paediatric obstructive sleep apnoea
Purpose: The high prevalence of non-alcoholic fatty liver disease (NAFLD) in obese children with obstructive sleep apnoea (OSA) calls for early non-invasive screening. The aim of this study was to use ultrasonographic liver echogenicity and elasticity to evaluate the early stages of liver injury in obese children with OSA. Methods: Fifty-five obese children with OSA aged 12 to 15 years were included. The control group (n = 56) consisted of healthy, non-obese children. All children underwent ultrasound examination to assess liver echogenicity using the hepatorenal index (HRI) and real-time elastography to determine the liver fibrosis index (LFI). Polysomnographic parameters, sonographic values, and clinical-biochemical assessment were statistically analysed according to OSA and its severity. Subgroup 1 was obese children with OSA and AHI < 5 and subgroup 2 was obese children with OSA and AHI ≥ 5. Results: Higher average values of HRI and LFI were recorded in the group of obese paediatric patients with OSA (mean age ± SD, 14.1 ± 2.2 year; 53% male; BMI z-score, 2.6 ± 0.35) compared to the control group (1.37 ± 0.19 vs. 1.12 ± 0.07, p < 0.001 and 1.82 ± 0.31 vs. 1.02 ± 0.27, p < 0.001). A significantly higher LFI was recorded in subgroup 2 compared to subgroup 1 (2.0 ± 0.3 vs. 1.6 ± 0.2, p < 0.001) while laboratory parameters and HRI (1.4 ± 0.2 vs. 1.4 ± 0.2, p = 0.630) did not change significantly. A strong positive correlation was found between the severity of OSA and the LFI (r = 0.454; p < 0.01). Conclusions: These findings suggest that ultrasound elastography is a useful non-invasive screening test for OSA-related steatohepatitis in obese adolescents, but other clinical studies are needed to confirm this result.
- 12 September 2024
- Published by Springer Nature in Sleep and Breathing
- Vol. 28 (6) , 2653-2661
Open AccessElastography as a non-invasive method of screening non-alcoholic fatty liver disease in the adult phenotype of paediatric obstructive sleep apnoea
Purpose: The high prevalence of non-alcoholic fatty liver disease (NAFLD) in obese children with obstructive sleep apnoea (OSA) calls for early non-invasive screening. The aim of this study was to use ultrasonographic liver echogenicity and elasticity to evaluate the early stages of liver injury in obese children with OSA. Methods: Fifty-five obese children with OSA aged 12 to 15 years were included. The control group (n = 56) consisted of healthy, non-obese children. All children underwent ultrasound examination to assess liver echogenicity using the hepatorenal index (HRI) and real-time elastography to determine the liver fibrosis index (LFI). Polysomnographic parameters, sonographic values, and clinical-biochemical assessment were statistically analysed according to OSA and its severity. Subgroup 1 was obese children with OSA and AHI < 5 and subgroup 2 was obese children with OSA and AHI ≥ 5. Results: Higher average values of HRI and LFI were recorded in the group of obese paediatric patients with OSA (mean age ± SD, 14.1 ± 2.2 year; 53% male; BMI z-score, 2.6 ± 0.35) compared to the control group (1.37 ± 0.19 vs. 1.12 ± 0.07, p < 0.001 and 1.82 ± 0.31 vs. 1.02 ± 0.27, p < 0.001). A significantly higher LFI was recorded in subgroup 2 compared to subgroup 1 (2.0 ± 0.3 vs. 1.6 ± 0.2, p < 0.001) while laboratory parameters and HRI (1.4 ± 0.2 vs. 1.4 ± 0.2, p = 0.630) did not change significantly. A strong positive correlation was found between the severity of OSA and the LFI (r = 0.454; p < 0.01). Conclusions: These findings suggest that ultrasound elastography is a useful non-invasive screening test for OSA-related steatohepatitis in obese adolescents, but other clinical studies are needed to confirm this result.